Erratum: Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 (Annals of Oncology (2015) 26(8) (1589–1604), (S0923753419318691), (10.1093/annonc/mdv257))

S. Gillessen; A. Omlin; G. Attard; J. S. de Bono; E. Efstathiou; K. Fizazi; S. Halabi; P. S. Nelson; O. Sartor; M. R. Smith; H. R. Soule; H. Akaza; T. M. Beer; H. Beltran; A. M. Chinnaiyan; G. Daugaard; I. D. Davis; M. De Santis; C. G. Drake; R. A. Eeles; S. Fanti; M. E. Gleave; A. Heidenreich; M. Hussain; N. D. James; F. E. Lecouvet; C. J. Logothetis; K. Mastris; S. Nilsson; W. K. Oh; D. Olmos; A. R. Padhani; C. Parker; M. A. Rubin; J. A. Schalken; H. I. Scher; A. Sella; N. D. Shore; E. J. Small; C. N. Sternberg; H. Suzuki; C. J. Sweeney; I. F. Tannock; B. Tombal

doi:10.1093/annonc/mdw180

Erratum: Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 (Annals of Oncology (2015) 26(8) (1589–1604), (S0923753419318691), (10.1093/annonc/mdv257))

S. Gillessen, A. Omlin, G. Attard, J. S. de Bono, E. Efstathiou, K. Fizazi, S. Halabi, P. S. Nelson, O. Sartor, M. R. Smith, H. R. Soule, H. Akaza, T. M. Beer, H. Beltran, A. M. Chinnaiyan, G. Daugaard, I. D. Davis, M. De Santis, C. G. Drake, R. A. EelesS. Fanti, M. E. Gleave, A. Heidenreich, M. Hussain, N. D. James, F. E. Lecouvet, C. J. Logothetis, K. Mastris, S. Nilsson, W. K. Oh, D. Olmos, A. R. Padhani, C. Parker, M. A. Rubin, J. A. Schalken, H. I. Scher, A. Sella, N. D. Shore, E. J. Small, C. N. Sternberg, H. Suzuki, C. J. Sweeney, I. F. Tannock, B. Tombal

Résultats de recherche: Contribution à un journal › !!Comment/debate

13 Citations (Scopus)

Résumé

Ann Oncol 2015; 26: 1589–1604 (doi: 10.1093/annonc/mdv257) The funding note for this publication was incomplete; the full funding note should read as follows: funding We gratefully acknowledge the financial support of the following non-profit organisations for the Advanced Prostate Cancer Consensus Conference (APCCC): Cantonal Hospital St Gallen, City and Canton of St Gallen, Swiss Cancer Research Organisation, European School of Oncology (ESO), Swiss Cancer League, the Swiss Oncology Research Network SAKK, Swiss Cancer Foundation, Prostate Cancer Foundation (PCF) and the Günter and Regine Kelm Foundation. We thank the Movember Foundation for the sponsoring of the travel grants (no grant number). We also acknowledge sponsorship from several different for-profit organisations including Abbvie, Amgen, Astellas, AstraZeneca, Bayer Health Care, Bucherer, Dendreon, Janssen, Mundipharma, Myriad, Novartis, Roche, Sanofi Oncology, Teva. (Details on the www.apccc.org). These for-profit organisations supported the conference financially but had no input in the scientific content or the publication.

langue originale	Anglais
Pages (de - à)	e3
journal	Annals of Oncology
Volume	30
Numéro de publication	12
Les DOIs	https://doi.org/10.1093/annonc/mdw180
état	Publié - 1 déc. 2019

Accès au document

10.1093/annonc/mdw180

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Gillessen, S., Omlin, A., Attard, G., de Bono, J. S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R., Soule, H. R., Akaza, H., Beer, T. M., Beltran, H., Chinnaiyan, A. M., Daugaard, G., Davis, I. D., De Santis, M., Drake, C. G., ... Tombal, B. (2019). Erratum: Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 (Annals of Oncology (2015) 26(8) (1589–1604), (S0923753419318691), (10.1093/annonc/mdv257)). Annals of Oncology, 30(12), e3. https://doi.org/10.1093/annonc/mdw180

@article{fd56d9fe35054bdca3eceb1b46d755f5,

title = "Erratum: Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 (Annals of Oncology (2015) 26(8) (1589–1604), (S0923753419318691), (10.1093/annonc/mdv257))",

abstract = "Ann Oncol 2015; 26: 1589–1604 (doi: 10.1093/annonc/mdv257) The funding note for this publication was incomplete; the full funding note should read as follows: funding We gratefully acknowledge the financial support of the following non-profit organisations for the Advanced Prostate Cancer Consensus Conference (APCCC): Cantonal Hospital St Gallen, City and Canton of St Gallen, Swiss Cancer Research Organisation, European School of Oncology (ESO), Swiss Cancer League, the Swiss Oncology Research Network SAKK, Swiss Cancer Foundation, Prostate Cancer Foundation (PCF) and the G{\"u}nter and Regine Kelm Foundation. We thank the Movember Foundation for the sponsoring of the travel grants (no grant number). We also acknowledge sponsorship from several different for-profit organisations including Abbvie, Amgen, Astellas, AstraZeneca, Bayer Health Care, Bucherer, Dendreon, Janssen, Mundipharma, Myriad, Novartis, Roche, Sanofi Oncology, Teva. (Details on the www.apccc.org). These for-profit organisations supported the conference financially but had no input in the scientific content or the publication.",

author = "S. Gillessen and A. Omlin and G. Attard and {de Bono}, {J. S.} and E. Efstathiou and K. Fizazi and S. Halabi and Nelson, {P. S.} and O. Sartor and Smith, {M. R.} and Soule, {H. R.} and H. Akaza and Beer, {T. M.} and H. Beltran and Chinnaiyan, {A. M.} and G. Daugaard and Davis, {I. D.} and {De Santis}, M. and Drake, {C. G.} and Eeles, {R. A.} and S. Fanti and Gleave, {M. E.} and A. Heidenreich and M. Hussain and James, {N. D.} and Lecouvet, {F. E.} and Logothetis, {C. J.} and K. Mastris and S. Nilsson and Oh, {W. K.} and D. Olmos and Padhani, {A. R.} and C. Parker and Rubin, {M. A.} and Schalken, {J. A.} and Scher, {H. I.} and A. Sella and Shore, {N. D.} and Small, {E. J.} and Sternberg, {C. N.} and H. Suzuki and Sweeney, {C. J.} and Tannock, {I. F.} and B. Tombal",

note = "Publisher Copyright: {\textcopyright} 2016 European Society for Medical Oncology",

year = "2019",

month = dec,

day = "1",

doi = "10.1093/annonc/mdw180",

language = "English",

volume = "30",

pages = "e3",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "12",

}

Gillessen, S, Omlin, A, Attard, G, de Bono, JS, Efstathiou, E, Fizazi, K, Halabi, S, Nelson, PS, Sartor, O, Smith, MR, Soule, HR, Akaza, H, Beer, TM, Beltran, H, Chinnaiyan, AM, Daugaard, G, Davis, ID, De Santis, M, Drake, CG, Eeles, RA, Fanti, S, Gleave, ME, Heidenreich, A, Hussain, M, James, ND, Lecouvet, FE, Logothetis, CJ, Mastris, K, Nilsson, S, Oh, WK, Olmos, D, Padhani, AR, Parker, C, Rubin, MA, Schalken, JA, Scher, HI, Sella, A, Shore, ND, Small, EJ, Sternberg, CN, Suzuki, H, Sweeney, CJ, Tannock, IF & Tombal, B 2019, 'Erratum: Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 (Annals of Oncology (2015) 26(8) (1589–1604), (S0923753419318691), (10.1093/annonc/mdv257))', Annals of Oncology, VOL. 30, Numéro 12, p. e3. https://doi.org/10.1093/annonc/mdw180

Erratum: Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 (Annals of Oncology (2015) 26(8) (1589–1604), (S0923753419318691), (10.1093/annonc/mdv257)). / Gillessen, S.; Omlin, A.; Attard, G. et al.
Dans: Annals of Oncology, Vol 30, Numéro 12, 01.12.2019, p. e3.

Résultats de recherche: Contribution à un journal › !!Comment/debate

TY - JOUR

T1 - Erratum

T2 - Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 (Annals of Oncology (2015) 26(8) (1589–1604), (S0923753419318691), (10.1093/annonc/mdv257))

AU - Gillessen, S.

AU - Omlin, A.

AU - Attard, G.

AU - de Bono, J. S.

AU - Efstathiou, E.

AU - Fizazi, K.

AU - Halabi, S.

AU - Nelson, P. S.

AU - Sartor, O.

AU - Smith, M. R.

AU - Soule, H. R.

AU - Akaza, H.

AU - Beer, T. M.

AU - Beltran, H.

AU - Chinnaiyan, A. M.

AU - Daugaard, G.

AU - Davis, I. D.

AU - De Santis, M.

AU - Drake, C. G.

AU - Eeles, R. A.

AU - Fanti, S.

AU - Gleave, M. E.

AU - Heidenreich, A.

AU - Hussain, M.

AU - James, N. D.

AU - Lecouvet, F. E.

AU - Logothetis, C. J.

AU - Mastris, K.

AU - Nilsson, S.

AU - Oh, W. K.

AU - Olmos, D.

AU - Padhani, A. R.

AU - Parker, C.

AU - Rubin, M. A.

AU - Schalken, J. A.

AU - Scher, H. I.

AU - Sella, A.

AU - Shore, N. D.

AU - Small, E. J.

AU - Sternberg, C. N.

AU - Suzuki, H.

AU - Sweeney, C. J.

AU - Tannock, I. F.

AU - Tombal, B.

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Ann Oncol 2015; 26: 1589–1604 (doi: 10.1093/annonc/mdv257) The funding note for this publication was incomplete; the full funding note should read as follows: funding We gratefully acknowledge the financial support of the following non-profit organisations for the Advanced Prostate Cancer Consensus Conference (APCCC): Cantonal Hospital St Gallen, City and Canton of St Gallen, Swiss Cancer Research Organisation, European School of Oncology (ESO), Swiss Cancer League, the Swiss Oncology Research Network SAKK, Swiss Cancer Foundation, Prostate Cancer Foundation (PCF) and the Günter and Regine Kelm Foundation. We thank the Movember Foundation for the sponsoring of the travel grants (no grant number). We also acknowledge sponsorship from several different for-profit organisations including Abbvie, Amgen, Astellas, AstraZeneca, Bayer Health Care, Bucherer, Dendreon, Janssen, Mundipharma, Myriad, Novartis, Roche, Sanofi Oncology, Teva. (Details on the www.apccc.org). These for-profit organisations supported the conference financially but had no input in the scientific content or the publication.

AB - Ann Oncol 2015; 26: 1589–1604 (doi: 10.1093/annonc/mdv257) The funding note for this publication was incomplete; the full funding note should read as follows: funding We gratefully acknowledge the financial support of the following non-profit organisations for the Advanced Prostate Cancer Consensus Conference (APCCC): Cantonal Hospital St Gallen, City and Canton of St Gallen, Swiss Cancer Research Organisation, European School of Oncology (ESO), Swiss Cancer League, the Swiss Oncology Research Network SAKK, Swiss Cancer Foundation, Prostate Cancer Foundation (PCF) and the Günter and Regine Kelm Foundation. We thank the Movember Foundation for the sponsoring of the travel grants (no grant number). We also acknowledge sponsorship from several different for-profit organisations including Abbvie, Amgen, Astellas, AstraZeneca, Bayer Health Care, Bucherer, Dendreon, Janssen, Mundipharma, Myriad, Novartis, Roche, Sanofi Oncology, Teva. (Details on the www.apccc.org). These for-profit organisations supported the conference financially but had no input in the scientific content or the publication.

UR - http://www.scopus.com/inward/record.url?scp=85079008198&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdw180

DO - 10.1093/annonc/mdw180

M3 - Comment/debate

C2 - 32036858

AN - SCOPUS:85079008198

SN - 0923-7534

VL - 30

SP - e3

JO - Annals of Oncology

JF - Annals of Oncology

IS - 12

ER -

Gillessen S, Omlin A, Attard G, de Bono JS, Efstathiou E, Fizazi K et al. Erratum: Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 (Annals of Oncology (2015) 26(8) (1589–1604), (S0923753419318691), (10.1093/annonc/mdv257)). Annals of Oncology. 2019 déc. 1;30(12):e3. doi: 10.1093/annonc/mdw180